phase 2_completion
saveMedical University of Gdansk — apixaban (Phase II Trial Completion)
community read0 votes
Therapy area: Cardiovascular, Oncology. Indication: Diffuse Large B-Cell Lymphoma, Hematological Tumor, Leukemia, Lymphoma, Multiple Myeloma (Kahler Disease), Myeloproliferative Disorders, Pulmonary Embolism, Thromboembolic Disease, Venous Thromboembolism
Data sources
globaldata
Found something off?
related news · 1
🐶 often sniffed alongside
top 8- drugapixaban5 co-mentions · 2 sources
- drugapixaban ER5 co-mentions · 2 sources
- tagOncology2 co-mentions · 1 sources
- tagHematology2 co-mentions · 1 sources
- tagAdCom2 co-mentions · 1 sources
- tag510(k) Clearance2 co-mentions · 1 sources
- tagDiagnostics Company2 co-mentions · 1 sources
- companyMedical University of Gdansk1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that